BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27033593)

  • 1. Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease.
    Mavropoulou A; Guazzetti S; Borghetti P; De Angelis E; Quintavalla C
    Vet J; 2016 May; 211():45-51. PubMed ID: 27033593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.
    Zois NE; Moesgaard SG; Kjelgaard-Hansen M; Rasmussen CE; Falk T; Fossing C; Häggström J; Pedersen HD; Olsen LH
    Vet J; 2012 Apr; 192(1):106-11. PubMed ID: 21696985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease.
    Ljungvall I; Höglund K; Carnabuci C; Tidholm A; Häggström J
    J Vet Intern Med; 2011; 25(5):1036-43. PubMed ID: 21848946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.
    Brüler BC; Jojima FS; Dittrich G; Giannico AT; Sousa MG
    J Vet Cardiol; 2018 Aug; 20(4):254-266. PubMed ID: 30031743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H; Berlanda M; Monacolli M; Contiero B; Coltro A; Guglielmini C
    J Vet Cardiol; 2017 Jun; 19(3):228-239. PubMed ID: 28579307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.
    Moesgaard SG; Aupperle H; Rajamäki MM; Falk T; Rasmussen CE; Zois NE; Olsen LH
    Res Vet Sci; 2014 Dec; 97(3):560-7. PubMed ID: 25458505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease.
    Ferasin L; Crews L; Biller DS; Lamb KE; Borgarelli M
    J Vet Intern Med; 2013; 27(2):286-92. PubMed ID: 23398050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q; Heaney A; Langenfeld-McCoy N; Boler BV; Laflamme DP
    BMC Vet Res; 2019 Nov; 15(1):425. PubMed ID: 31775756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
    Li Q; Freeman LM; Rush JE; Laflamme DP
    Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of canine myxomatous mitral valve disease.
    O'Brien MJ; Beijerink NJ; Wade CM
    Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D; Caivano D; Matos JN; Summerfield N; Rishniw M
    J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial volume and function in dogs with naturally occurring myxomatous mitral valve disease.
    Höllmer M; Willesen JL; Tolver A; Koch J
    J Vet Cardiol; 2017 Feb; 19(1):24-34. PubMed ID: 27825670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
    Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D; Rishniw M; Birettoni F; Patata V; Giorgi ME; Porciello F
    J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.